Clinical Trials Browser

Lymphoma, T-Cell, Cutaneous × Brentuximab Vedotin × 90 days × Clear all

NCT05414500 2026-04-09

Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

Phase 1 Recruiting

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous